CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefepime And Dextrose In Duplex Container patents expire, and what generic alternatives are available?
Cefepime And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER is cefepime hydrochloride. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime And Dextrose In Duplex Container
A generic version of CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER?
- What are the global sales for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER?
- What is Average Wholesale Price for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER?
Summary for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER at DailyMed |
Pharmacology for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
| Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER | cefepime hydrochloride | INJECTABLE;INJECTION | 050821-001 | May 6, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER | cefepime hydrochloride | INJECTABLE;INJECTION | 050821-002 | May 6, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
